Curaleaf

Corporate brand

Curaleaf is a vertically integrated cannabis company producing and distributing cannabis products through cultivation, processing, brands, and dispensaries.

Last updated August 31, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Curaleaf is an American cannabis company headquartered in Stamford, Connecticut, with operations spanning cultivation, processing, branded products, distribution, and retail dispensaries. Although it is publicly traded in Canada, its principal corporate identity and operating base are American. The company serves regulated cannabis markets in the United States and, through its European platform, selected markets including the United Kingdom, Germany, Italy, Spain, and Portugal. The business was established in 2010 under the name PalliaTech. Its early activities included operations in New Jersey and a research center in Colorado. In 2013, the investment group Sputnik acquired a 35 percent interest, helping provide capital for subsequent expansion. PalliaTech adopted the Curaleaf name in 2018, shortly before listing on the Canadian Securities Exchange under the symbol CURA. The company raised $400 million in its public offering, described in the reference material as the largest stock offering in the cannabis industry at that time. Curaleaf expanded primarily through a combination of organic cultivation and retail development and a series of acquisitions. In 2019, it acquired Select, a cannabis oil brand, strengthening its branded-product portfolio and helping make Curaleaf the largest cannabis operator in the United States. In 2020, it purchased BlueKudu, a Colorado-based maker of infused chocolates and gummies. Later that year, its acquisition of Chicago-based Grassroots Cannabis expanded the business into 23 U.S. states and made Curaleaf the world's largest cannabis company by revenue according to the cited reference material. International growth became a further strategic focus in 2021. Curaleaf completed its acquisition of EMMAC Life Sciences, described as Europe's largest independent vertically integrated cannabis company. The transaction added cultivation, European Union Good Manufacturing Practice-certified processing, distribution, and research and development capabilities in several European cannabis markets. Curaleaf also agreed to acquire Los Sueños Farms, a 36-acre outdoor cannabis cultivation operation in Colorado, for more than $60 million. Curaleaf's portfolio includes cannabis flower, oils, concentrates, edibles, gummies, chocolates, and other regulated cannabis formats, sold through its own retail network and other permitted channels. Its business model emphasizes vertical integration, allowing the company to control multiple stages from cultivation and product development through distribution and dispensary sales. The company operates in a heavily regulated industry, so market access, product labeling, licensing, testing, and local cannabis rules materially shape its operations. The brand's growth has also involved regulatory risk. In 2021, an Oregon subsidiary mistakenly distributed THC-containing tinctures labeled as CBD-only products. The Oregon Liquor and Cannabis Commission responded with a recall. This incident illustrates the compliance challenges associated with manufacturing and labeling cannabis products across multiple jurisdictions. Despite such issues, Curaleaf remained an active major cannabis company and, based on the cited material, was the world's largest cannabis company by revenue as of 2025.

History

Curaleaf began in 2010 as PalliaTech, an early cannabis business with operations in New Jersey and a research center in Colorado. Its development took place during a period when cannabis legalization was expanding unevenly across the United States, requiring operators to build state-by-state cultivation, processing, and retail capabilities. In 2013, the investment group Sputnik acquired a 35 percent stake in the company, providing a significant ownership and capital connection during its formative period. The company adopted the Curaleaf name in 2018. Around the same time, it became publicly traded on the Canadian Securities Exchange under the symbol CURA. Its public offering raised $400 million and was described in the cited material as the largest stock offering in cannabis-industry history at that point. The Canadian listing reflected the limited availability of major public-market routes for cannabis businesses while the company's operating activities remained concentrated in the United States. Curaleaf's principal growth strategy was vertical integration supported by acquisitions. In 2019, it bought Select, a cannabis oil brand. The deal broadened Curaleaf's branded portfolio and contributed to its position as the largest cannabis operator in the United States. In 2020, the company acquired BlueKudu, a Colorado edibles producer associated with infused chocolates and gummies. It also bought Grassroots Cannabis, a Chicago-based competitor. The Grassroots transaction expanded Curaleaf's footprint to 23 U.S. states and, according to the cited reference, made the company the world's largest cannabis company by revenue. The company's expansion was not limited to North America. In April 2021, Curaleaf completed its previously announced acquisition of EMMAC Life Sciences Limited. EMMAC was described as Europe's largest independent vertically integrated cannabis company. Through the transaction, Curaleaf obtained cultivation, EU GMP-certified processing, distribution, and research and development operations in several European markets, including the United Kingdom, Germany, Italy, Spain, and Portugal. The acquisition gave Curaleaf a platform for international medical and regulated cannabis activities beyond its extensive U.S. presence. In May 2021, Curaleaf announced a definitive agreement to acquire Los Sueños Farms, a 36-acre outdoor cannabis-growing operation in Colorado, for more than $60 million. The deal represented continued investment in cultivation capacity and supply-chain control in a key U.S. cannabis market. Curaleaf's operating model combines production and retail. Its activities include cannabis cultivation, product processing, brand development, distribution, and dispensary operations. Its product range includes flower, oils, tinctures, concentrates, edibles, chocolates, and gummies, with Select and BlueKudu serving as notable acquired brands. The company therefore competes both as a consumer-products producer and as a regulated retail operator. The business has also faced compliance challenges associated with operating across multiple cannabis jurisdictions. In September 2021, Curaleaf's Oregon subsidiary Cura Cannabis mistakenly distributed THC tinctures that had been labeled as containing only CBD. The Oregon Liquor and Cannabis Commission initiated a recall. The event highlighted the importance of accurate formulation, testing, labeling, and state-level regulatory controls in Curaleaf's operating model. By 2025, the cited reference characterized Curaleaf as the world's largest cannabis company by revenue. Its history is consequently defined by rapid consolidation, vertical integration, public-market financing, expansion across U.S. states, and entry into selected European markets. The company remains subject to the legal and commercial constraints of the cannabis sector, including differing rules between jurisdictions, product-safety requirements, and regulatory oversight of cultivation, manufacturing, distribution, and retail sales.

2021
EMMAC acquisition completed
[1]Curaleafen.wikipedia.org
Curaleaf completes its purchase of EMMAC Life Sciences and gains a platform in several European cannabis markets.
2021
Los Sueños Farms agreement
[1]Curaleafen.wikipedia.org
Curaleaf agrees to acquire the 36-acre Colorado outdoor cultivation business Los Sueños Farms.
2021
Oregon tincture recall
[1]Curaleafen.wikipedia.org
Cura Cannabis recalls THC-containing tinctures that were mislabeled as CBD-only products.
2020
BlueKudu acquisition
[1]Curaleafen.wikipedia.org
Curaleaf acquires Colorado edibles maker BlueKudu.
2020
Grassroots Cannabis acquisition
[1]Curaleafen.wikipedia.org
The Grassroots transaction expands Curaleaf's U.S. presence to 23 states.
2019
Select acquisition
[1]Curaleafen.wikipedia.org
Curaleaf acquires the cannabis oil brand Select.
2018
PalliaTech becomes Curaleaf
[1]Curaleafen.wikipedia.org
The company changes its name to Curaleaf and lists on the Canadian Securities Exchange under CURA, raising $400 million.
2013
Sputnik acquires a minority stake
[1]Curaleafen.wikipedia.org
Investment group Sputnik purchases a 35 percent interest in the company.
2010
PalliaTech is founded
[1]Curaleafen.wikipedia.org
The business that later became Curaleaf is established under the name PalliaTech, with operations in New Jersey and a research center in Colorado.

Products and positioning

A large, vertically integrated cannabis company combining cultivation, branded products, processing, distribution, and dispensary retail across regulated North American and European markets.

Cannabis flower
Curaleaf cannabis flower
Cannabis flower is one of the core product formats associated with Curaleaf's cultivation and dispensary operations. Products are produced and sold within applicable state or national regulatory systems, where rules govern cultivation, testing, packaging, labeling, and retail distribution. The format supports both medical and adult-use market participation where legally permitted.
Cannabis oils and branded products
Select
Select is a cannabis oil brand acquired by Curaleaf in 2019. Its purchase strengthened Curaleaf's branded-product platform and added a recognizable oil-focused business to the company's vertically integrated portfolio. Availability and product formats vary according to the rules of each regulated market.
Cannabis edibles
BlueKudu
BlueKudu is a Colorado-based edibles maker acquired by Curaleaf in 2020. The brand is associated with infused chocolates and gummies, giving Curaleaf additional capabilities in portioned, packaged cannabis products and extending its range beyond flower and oil formats.
Cannabis extracts
Cannabis oils and tinctures
Curaleaf produces and distributes oil-based cannabis products, including tinctures and other extract formats. These products are subject to strict jurisdiction-specific requirements concerning cannabinoid content, testing, dosage information, packaging, and labeling. The category includes the oil capabilities associated with the Select brand.
Edible cannabis products
Cannabis edibles
Curaleaf's edible portfolio includes products such as gummies and infused chocolates, supported in part by the BlueKudu acquisition. Edibles provide a non-inhaled consumption format and require controlled dosing, ingredient disclosure, testing, and child-resistant packaging where required by local regulators.
Cannabis retail
Curaleaf dispensary offerings
Curaleaf's dispensaries provide regulated cannabis products directly to consumers and patients in jurisdictions where the company holds the necessary licenses. Retail offerings can include flower, oils, concentrates, edibles, and other permitted formats. The assortment, purchasing rules, and medical or adult-use status differ by state or country.

Controversies

2022
Curaleaf settles 10 lawsuits over THC-contaminated CBD drops
Curaleaf settled 10 lawsuits stemming from a mix-up in which an employee unintentionally added THC-containing raw material to a batch of its Select-branded CBD tincture. Three additional cases were headed to trial, according to the attorney representing the claimants.
Source
2021
Oregon THC tincture labeling incident
Curaleaf subsidiary Cura Cannabis mistakenly distributed tinctures containing THC while labeling them as products containing only CBD. The Oregon Liquor and Cannabis Commission responded with a recall, making the incident a notable product-safety and regulatory compliance matter.
Source

2021
Expand into Europe through EMMACM&A
Background
Curaleaf sought an international platform in regulated European cannabis markets.
Action taken
It completed the acquisition of EMMAC Life Sciences.
Aftermath
Curaleaf gained cultivation, EU GMP-certified processing, distribution, and research and development capabilities in several European countries.
Source
2021
Acquire Los Sueños FarmsM&A
Background
Curaleaf continued investing in controlled cultivation capacity and supply in Colorado.
Action taken
The company signed a definitive agreement to acquire the 36-acre outdoor cannabis cultivation operation Los Sueños Farms.
Aftermath
The agreement expanded Curaleaf's cultivation resources in Colorado.
Reported transaction value. More than $60 million (2021 announced agreement)
Source
2020
Acquire Grassroots CannabisM&A
Background
Curaleaf pursued geographic expansion in the fragmented U.S. cannabis market.
Action taken
It acquired Chicago-based competitor Grassroots Cannabis.
Aftermath
The transaction expanded Curaleaf's presence to 23 U.S. states and supported its position as the world's largest cannabis company by revenue according to the cited reference.
Source
2019
Acquire SelectM&A
Background
Curaleaf sought to expand its branded cannabis-oil business and strengthen its U.S. operating position.
Action taken
It acquired Select, a cannabis oil brand.
Aftermath
The acquisition contributed to Curaleaf becoming the largest cannabis operator in the United States.
Source
2018
Adopt the Curaleaf name and pursue a public listingStrategy
Background
The company formerly known as PalliaTech sought to establish a broader consumer-facing identity and access public-market capital.
Action taken
It changed its name to Curaleaf and listed on the Canadian Securities Exchange under CURA.
Aftermath
The offering raised $400 million and provided a public-market platform for subsequent expansion.
Capital raised. $400 million (2018 public offering)
Source

Recent events

2026.11.02
Reported2026.11.02
Curaleaf acquires an interest in Boone Town Provisions[3]Curaleaf 收购 Boone Town Provisions 股权prnewswire.com
Curaleaf Holdings announced that it had acquired an equity stake and certain operating rights in Boone Town Provisions, a dispensary in Boonton, New Jersey. The acquisition expanded Curaleaf's New Jersey footprint to four dispensaries.
2022.03.14
Reported2022.03.15
Curaleaf CFO Ranjan Kalia to leave company[4]Curaleaf首席财务官Ranjan Kalia将离职prnewswire.com
Curaleaf announced that its current CFO, Ranjan Kalia, is leaving the company to pursue other career opportunities.
2022.02.02
Reported2022.02.02
Curaleaf and Repsly announce a retail technology partnership[5]Curaleaf与Repsly宣布零售技术合作prnewswire.com
Curaleaf and Repsly announced a technology partnership to support Curaleaf's wholesale operations across the US with CRM solutions, retail execution support, and business analytics and insights. Curaleaf said it would begin rolling out the Repsly platform in February 2022.
Unconfirmed
Reported2022.01.07
Curaleaf settles 10 lawsuits over THC-contaminated CBD drops[2]Curaleaf settles 10 lawsuits over THC-contaminated CBD dropsnewsweek.com
Curaleaf settled 10 lawsuits stemming from a mix-up in which an employee unintentionally added THC-containing raw material to a batch of its Select-branded CBD tincture. Three additional cases were headed to trial, according to the attorney representing the claimants.
2021.12.28
Reported2021.12.28
Curaleaf announces agreement to acquire Bloom Dispensaries[6]Curaleaf宣布协议收购Bloom Dispensariesprnewswire.com
Curaleaf announced that it had entered into a definitive agreement to acquire Arizona cannabis operator Bloom Dispensaries in an all-cash transaction valued at approximately US$211 million. The acquisition was expected to close in January 2022, subject to approvals and other conditions.
2021.10.26
Reported2021.10.26
Curaleaf begins New York whole-flower sales[7]Curaleaf在纽约开始销售整花大麻产品prnewswire.com
Curaleaf announced that its initial batches of New York whole flower had cleared third-party laboratory testing and that sales of three strains would begin at its Newburgh location on October 26, with availability at three other dispensaries the following day.
2021.10.21
Reported2021.10.21
Select and Rolling Stone expand co-branded product line[8]Select与Rolling Stone拓展联名产品线finance.yahoo.com
Curaleaf’s Select brand signed a deal with Rolling Stone to expand the Rolling Stone by Select co-branded product line to other U.S. markets.
2021.07.12
Reported2021.07.12
Curaleaf announces CFO appointment[9]Curaleaf宣布首席财务官任命investingnews.com
Curaleaf announced that Ranjan Kalia will join the company as chief financial officer on July 19, 2021, succeeding Michael Carlotti, who is stepping down for medical reasons.
2021.04.22
Reported2021.04.22
Curaleaf announces hiring partnership with Mass CultivatED[10]Curaleaf announces hiring partnership with Mass CultivatEDwickedlocal.com
Curaleaf Holdings Inc. announced a hiring partnership with Mass CultivatED, aligned with its Rooted in Good initiative.
2021.04.15
Reported2021.04.15
Curaleaf opens Westmont recreational cannabis store[11]Curaleaf在韦斯特蒙特开设休闲大麻门店patch.com
Curaleaf opened a recreational cannabis store in Westmont, Illinois, its 10th location in the state.

Sources25 sources

Cite this profile: Cite the canonical profile. /brand-wiki/curaleaf · Editorial policy · How profiles are compiled